Serinus Biosciences YCアプリケーション

Summer 2022Active

Serinus BiosciencesはSummer 2022バッチでHealthcare企業としてY Combinatorを卒業しました。以下：会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。

YCバッチ: Summer 2022
業界: HealthcareTherapeutics
チーム規模: 6
ステータス: Active
ローンチ済み: 2022

創業者

Adam YaariFounder/CEO
Maxwell ShermanFounder/CTO

Serinus Biosciencesの事業内容

Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.

Serinus BiosciencesのYCアプリケーション、再構築済み

Y Combinator 申請

Serinus Biosciences 様、Summer 2022 バッチ。公開データから回答された、実際のフォームの質問。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Serinus Biosciences

Describe what your company does in 50 characters or less.

Combinations therapy by rational design

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI platform that designs combination therapies to overcome cancer treatment resistance. Our system uses decades of system biology knowledge to model how cancer evolves escape routes to therapies, allowing us to propose molecule combinations that are more effective and safer. The output is explainable, letting researchers and clinicians understand why the selected combinations work.

Where do you live now, and where would the company be based after YC?

We live and operate in New York, NY, USA, and plan to keep the company based here after YC.

Explain your decision regarding location.

New York is a biotech and healthcare innovation hub with access to top academic partners and talent. Staying here lets us collaborate closely with our scientific advisors and prospective customers while benefiting from YC's remote-friendly approach.

フルアプリケーションで21件の追加回答

はフルバージョンにあります。無料アカウントを作成して、他のすべてのYCバッチの横にあるYCインサイトで開いてください。

申請内容全体を見る

よくある質問

Serinus Biosciencesの実際のYCアプリケーションですか？

いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、Serinus Biosciencesの公開データ（ローンチノート、創業者経歴、製品説明）から回答しています。Serinus Biosciencesのような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。